[1]陈晓帆,郭育君,侯 超,等.通痹活络汤联合虎符铜砭刮痧法及耳穴压豆治疗脑梗死疗效研究[J].陕西中医,2022,(9):1196-1199.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.009]
　CHEN Xiaofan,GUO Yujun,HOU Chao,et al.Clinical effect study on Tongbi Huoluo decoction combined with Hufu Tongbian scraping method and auricular point pressing beans on patients with cerebral infarction[J].,2022,(9):1196-1199.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.009]
点击复制

通痹活络汤联合虎符铜砭刮痧法及耳穴压豆治疗脑梗死疗效研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2022年9期
页码:
1196-1199
栏目:
临床研究
出版日期:
2022-09-05

文章信息/Info

Title:
Clinical effect study on Tongbi Huoluo decoction combined with Hufu Tongbian scraping method and auricular point pressing beans on patients with cerebral infarction
作者:
陈晓帆1; 2; 郭育君1; 2; 侯 超1; 2; 杨 俊1; 2; 谢 婷1; 2; 练宇泽1; 2; 周旭辉1; 2
(1.湖南中医药大学临床医学院,湖南 长沙410007; 2.湖南省脑科医院精神科,湖南 长沙 410007)
Author(s):
CHEN Xiaofan; GUO Yujun; HOU Chao; YANG Jun; XIE Ting; LIAN Yuze; ZHOU Xuhui
(Clinical Medical College of Hunan University of Traditional Chinese Medicine,Changsha 410007,China)
关键词:
脑梗死;  通痹活络汤;  虎符铜砭刮痧法;  耳穴压豆;  血液流变学;  T淋巴细胞;  炎症因子
Keywords:
Cerebral infarction;  Tongbi Huoluo decoction;  Hufu Tongbian scraping method;  Auricular point pressing beans;  Hemorheology;  T-lymphocytes;  Inflammatory factor
分类号:
R 255.2
DOI:
DOI:10.3969/j.issn.1000-7369.2022.09.009
文献标志码:
A
摘要:
目的:探讨通痹活络汤联合虎符铜砭刮痧法与耳穴压豆治疗脑梗死临床疗效。方法:选取脑梗死患者97例,随机抽层法分为对照组、联合治疗组,对照组使用虎符铜砭刮痧法与耳穴压豆治疗,联合治疗组使用通痹活络汤联合耳穴压豆治疗。比较两组中医证候评分、血浆黏度、全血高切黏度、红细胞比积、CD3+、CD4+、CD8+、C反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)、白介素-6(IL-6)水平以及两组临床治疗效果。结果:治疗后,对照组眩晕、不语、头痛评分高于联合治疗组(均P<0.05)。治疗后,对照组患者血浆黏度、全血高切黏度、CD8+、hs-CRP、TNF-α、IL-6水平高于联合治疗组,红细胞比积、CD3+、CD4+水平低于联合治疗组(均P<0.05)。联合治疗组治疗总有效率高于对照组,差异有统计学意义(P<0.05)。结论:通痹活络汤联合虎符铜砭刮痧法与耳穴压豆治疗脑梗死,可降低中医证候评分,改善患者血液流变学指标,调节T淋巴细胞水平,减轻炎症反应,治疗效果较好。
Abstract:
Objective:To analyze clinical efficacy of Tongbi Huoluo decoction combined with Hufu Tongbian scraping method and auricular point pressing beans on patients with cerebral infarction.Methods:97 patients with cerebral infarction were selected and randomly divided into control group and combined treatment group.The control group was treated with Hufu Tongbian scraping method and auricular acupoint pressing.The combined treatment group was treated with Tongbi Huoluo decoction combined with auricular acupoint pressing.TCM syndrome score,plasma viscosity,whole blood high shear viscosity,hematocrit were compared between the two groups.The levels of CD3+,CD4+ and CD8+ were detected by flow cytometry.The levels of hs-CRP,TNF-α and interleukin-6(IL-6)were detected by enzyme-linked immunosorbent assay.The clinical treatment effect was compared between the two groups.Results:After treatment,the scores of dizziness,silence and headache in the control group were higher than those in the combined treatment group(all P<0.05).After treatment,the levels of plasma viscosity,whole blood high shear viscosity,CD8+,hs-CRP,TNF-α and IL-6 in the control group were higher than those in the combined treatment group,while hematocrit,levels of CD3+ and CD4+ were lower than those in the combined treatment group(all P<0.05).The effective rate of the control group was lower than that of the combined treatment group(P<0.05).Conclusion:Tongbi Huoluo decoction combined with Hufu Tongbian scraping method and auricular acupoint pressing bean in the treatment of cerebral infarction,the patient's TCM syndrome score decreased,hemorheology improved,T lymphocyte level was regulated,inflammatory response were alleviated,and better effect.

参考文献/References:

[1] Rass V,Helbok R.How to diagnose delayed cerebral ischaemia and symptomatic vasospasm and prevent cerebral infarction in patients with subarachnoid haemorrhage[J].Curr Opin Crit Care,2021,27(2):103-114.
[2] Takeda H,Yamaguchi T,Yano H,et al.Microglial metabolic disturbances and neuro-inflamation in cerebral infarction[J].Journal Pharmacol Sci,2021,145(1):130-139.
[3] 薛亚妮,刘 瑞,陈 彭,等.依达拉奉注射液联合阿替普酶静脉溶栓治疗急性脑梗死临床疗效观察[J].陕西医学杂志,2021,50(6):731-734.
[4] 包 蕾.阿加曲班联合阿司匹林治疗急性脑梗死疗效及对患者血管内皮功能的影响[J].陕西医学杂志,2021,50(5):603-605,625.
[5] Kaesmacher J,Ospel JM,Meinel TR,et al.Thrombolysis in cerebral infarction reperfusions:To treat or to stop[J].Stroke,2020,51(11):3461-3471.
[6] 赵 琴.通痹活络汤联合依达拉奉对急性脑梗死患者血清CXCL-16、MCP-1和GDF-15的影响[J].西部中医药,2022,35(1):16-20.
[7] Ahmar M,Koch F,Gabrielian D,et al.Vom oesophaguskarzinom zum hirninfarkt esophageal cancer leading to a cerebral infarction[J].Chirurg,2021,92(3):264-268.
[8] 中华医学会急诊医学分会卒中学组,中国卒中学会急救医学分会.急性脑梗死溶栓治疗急诊绿色通道构建专家共识[J].中国急救医学,2017,37(8):681-684.
[9] 高梦菲,王朝霞.益肾健脑汤联合针刺对脑梗死后轻度认知障碍患者血清miR-27-3p、miR-409-3p表达的影响[J].陕西中医,2022,43(3):371-375.
[10] 时晋泰,王中琳,吴宣美.中药内服联合针灸推拿对急性脑梗死患者神经功能缺损评分及凝血功能的影响[J].陕西中医,2021,42(12):1783-1785.
[11] Zhang WT,Niu JY,He C.Associations of OSAHS complicated by cerebral infarction with intestinal flora inflammatory factors homocysteine and adiponectin expression[J].Eur Rev Med Pharmacol Sci,2020,24(24):12993-12999.
[12] 辛铭正,曹晓岚,孙灵芝.基于络病理论探讨分水岭脑梗死的病理机制及中医药治疗进展[J].实用心脑肺血管病杂志,2021,29(3):128-131.
[13] Luo W,Wei MG,Wei HL,et al.Cerebral infarction after drug-eluting bead bronchial arterial chemoembolization due to the mechanical force-mediated opening of an errant passage[J].Chin Med Journal,2020,134(8):989-990.
[14] Ueta Y,Akiba Y,Yamazaki J,et al.Cerebral infarction and myalgia in a 75-year-old man with eosinophilic granulomatosis with polyangiitis[J].Intern Med,2020,59(23):3089-3092.
[15] 彭 杰,李洁琼,熊元元.舒血宁注射液对急性脑梗死病人血液流变学及生活质量的影响[J].中西医结合心脑血管病杂志,2021,19(11):1914-1916.
[16] 任厚伟,顾 彬,郭 婷,等.急性脑梗死患者并发脑卒中相关性肺炎外周血T淋巴细胞亚群与炎症因子的临床分析[J].中华临床感染病杂志,2020,13(6):406-411.
[17] 李 永,刘 彬,王 荣.替罗非班对急性脑梗死患者炎症因子及免疫功能的影响研究[J].重庆医学,2021,50(4):630-633.
[18] 朱俊清,俞镜清.长春西汀结合尤瑞克林对急性脑梗死患者炎症反应、神经功能及免疫功能的影响[J].广东医学,2021,42(7):849-853.
[19] Satpathy DK,Mitra C,Samal P,et al.Delayed cerebral infarction following trans-sylvian surgery for craniopharyngioma presenting as status epilepticus[J].Neurol India,2020,68(6):1428-1430.
[20] 臧艳静,崔泽岩,郑宏伟.血清UA、NSE、Hcy及炎症因子在预测脑梗死患者预后中的价值[J].国际检验医学杂志,2021,42(16):1977-1981.
[21] 柳淑青,原 晨,张丽娜,等.加味化痰通络汤联合他汀药物对脑梗死气虚痰瘀互阻证患者免疫炎症和神经功能的影响[J].中国中医急症,2021,30(6):1067-1070.

相似文献/References:

[1]郭 辉,裴 育,熊伟华,等.血府逐瘀汤联合阿替普酶静脉溶栓对急性脑梗死患者 神经功能及日常生活能力的影响*[J].陕西中医,2019,(2):214.
　GUO Hui,PEI Yu,XIONG Weihua,et al.Effect of Xuefu Zhuyu decoction combined with intravenous thrombolysis on the neurological function and activities of daily living in patients with acute cerebral infarction[J].,2019,(9):214.
[2]陈 晨.补阳还五汤对急性脑梗死患者血管内皮生长因子、血管生成素2及神经功能影响的研究*[J].陕西中医,2019,(1):28.
[3]王艳民.开窍活血汤对脑梗死患者血清前白蛋白、MCP1及MMP9的影响*[J].陕西中医,2019,(1):34.
[4]贾东佩,李春雷△.调神通络针刺法对脑梗死后血管性痴呆患者血清BDNF、VEGF、MMP9的影响*[J].陕西中医,2019,(1):119.
　JIA Dongpei,LI Chunlei..Effect of Tiaoshen Tongluo acupuncture in patients with vascular dementia after cerebral infarction and its effects on serum BDNF, VEGF and MMP9[J].,2019,(9):119.
[5]周志梅,买 雷,李艳红.消栓肠溶胶囊治疗脑梗死疗效及对患者NIHSS评分的影响*[J].陕西中医,2019,(6):696.
　ZHOU Zhimei,MAI Lei,LI Yanhong..Effect of Xiaoshuan enteric-coated capsule on patients with cerebral infarction and its influence on NIHSS score of patients[J].,2019,(9):696.
[6]项广宇.化痰通络方治疗短暂性脑缺血发作后脑梗死疗效及对患者氧化应激和血清相关细胞因子水平的影响*[J].陕西中医,2019,(7):864.
[7]陈 静,陈 炜,伍 媛,等.小续命汤及其组分治疗急性脑梗死研究进展*[J].陕西中医,2019,(12):1818.
[8]赵月臣,马 兰.痰瘀阻络方联合丁苯酞治疗脑梗死急性期疗效及对患者脑血流灌注及血清6-k-PGF1a、Hcy、sICAM-1水平影响*[J].陕西中医,2020,(2):174.
　ZHAO Yuechen,MA Lan..Effect of phlegm stasis blocking collateral combined with butylphthalide on cerebral blood flow perfusion and serum 6-k-PGFla,Hcy and sICAM-1 level in patients with acute cerebral infarction[J].,2020,(9):174.
[9]黄英媛,宋振华△,徐焕杰,等.补阳还五汤联合梅花针叩刺治疗脑梗死偏瘫疗效研究*[J].陕西中医,2020,(6):815.[doi:DOI:10.3969/j.issn.10007369.2020.06.033]
　HUANG Yingyuan,SONG Zhenhua,XU Huanjie,et al.Clinical effect of Buyang Huanwu decoction combined with plum flower needle tapping on cerebral infarction hemiplegia[J].,2020,(9):815.[doi:DOI:10.3969/j.issn.10007369.2020.06.033]
[10]韩 慧,赖智勇,蒲建萍,等.头穴丛刺法联合川芎嗪对大鼠脑梗死后神经元突触重建的影响*[J].陕西中医,2020,(7):860.[doi:DOI:10.3969/j.issn.10007369.2020.07.006]
　HAN Hui,LAI Zhiyong,PU Jianping,et al.Effect of scalp acupuncture combined with ligustrazine on synaptic reconstruction of neurons after cerebral infarction in rats[J].,2020,(9):860.[doi:DOI:10.3969/j.issn.10007369.2020.07.006]

备注/Memo

备注/Memo:
基金项目:国家重点研发计划项目(2018YFC1314401); 湖南省自然科学基金资助项目(2021JJ70013,2021JJ70089,2018JJ3284); 湖南省卫生健康委员会科研项目(20200620,202103092373)
更新日期/Last Update: 2022-09-08